Skip to content

PeerfordResearch intelligence

Countries
Institutions
Researchers
Fields
Rankings
Compare
Commons

Search institutions, scholars, countries and publications

Countries
Institutions
Researchers
Fields
Rankings
Compare

CommonsWhere researchers talk about their work

Search institutions, scholars, countries and publications

Every figure here is counted by Peerford from the works themselves, the same way for every institution.

Browse

Countries
Institutions
Researchers
Fields
Rankings
Commons, for researchers

About

How Peerford counts
Compare institutions
Privacy
Terms of use

Contact

hello@peerford.com
https://wa.me/peerford · WhatsApp

Language

English
FrançaisFrench
PortuguêsPortuguese
العربيةArabic

Theme

SystemLightDark

Sagiru Hamza Abdullahi · Peerford

Ahmadu Bello University / Scholars

SA

Sagiru Hamza Abdullahi

Ahmadu Bello University

Publishing since 2021, latest 2026

Organic Chemistry
Computational Theory and Mathematics
Molecular Biology
Genetics
Oncology
Toxicology

ORCID 0000-0002-2976-9636
Their record on OpenAlex

Publications: 162021–2026
Citations: 325to those papers
h-index: 10i10-index 10
Field-weighted impact: 2.391.00 is the world average
World top 10%: 44%7 of 16 scored papers
Open access: 75%12 papers free to read

By year

Papers, and the citations to them

Publications, left axisCitations to that year’s papers, right axis2026 still in progress

Citations received each year

Peerford

To all their work, old papers included. Google Scholar also counts citations from theses, books and web pages, so its line runs higher.

What they work on

From the classification of each paper

Subfields

Organic Chemistry1381%

Publications

16 in all

Newest Most cited Oldest Title

Search their publications by title

DFT and molecular dynamics exploration of 2-[2-(hydroxybenzylidene)amino]benzoic acid, and (2-hydroxybenzylidene)-(2-hydroxyphenyl)amine Schiff bases as green corrosion inhibitors for mild steel
2026Discover Chemistry.JournalOpen accessSenior author1 citation10.1007/s44371-026-00489-9
In Silico evaluation of naphthalene-based tubulin inhibitors as potential anticancer agents targeting breast cancer cells

Download CV:PDF · Word

Who they write with Where their co-authors are Every publication

Is this you? Sign in to edit your profile

Computational Theory and Mathematics1275%

Molecular Biology319%

Genetics213%

Oncology213%

Toxicology213%

Civil and Structural Engineering16%

Electrical and Electronic Engineering16%

Immunology16%

Materials Chemistry16%

Health Sciences
Life Sciences
Physical Sciences

Topics most written on

Computational Drug Discovery Methods12
Synthesis and biological activity12
Quinazolinone synthesis and applications4
Bioactive Compounds and Antitumor Agents2
Click Chemistry and Applications2
Cytokine Signaling Pathways and Interactions2
Estrogen and related hormone effects2
Synthesis and Biological Evaluation2
Angiogenesis and VEGF in Cancer1
Atherosclerosis and Cardiovascular Diseases1
Cancer Mechanisms and Therapy1
Cancer therapeutics and mechanisms1

Who they write with

Their most frequent co-authors, and the papers those co-authors share

Where their co-authors are

25% of their papers have a co-author abroad

papers co-written1111111Home

Most frequent partner countries

Bangladesh1
Canada1
India1
Poland1
Turkey1

Papers with at least one author in that country.

Institutions written with most

Sa'adu Zungur UniversityNG2 papers
Bayero University KanoNG2 papers
Gautam Buddha UniversityIN1 paper
Gaziantep UniversityTR1 paper
Jawaharlal Nehru UniversityIN1 paper
Notre Dame University BangladeshBD1 paper
University of CalgaryCA1 paper
University of ChittagongBD1 paper
Warsaw University of TechnologyPL1 paper
Enugu State University of Science and TechnologyNG1 paper

Where they publish

Bulletin of the National Research Centre/Bulletin of the National Research Center3
Scientific African3
Chemistry Africa2
Biocatalysis and Agricultural Biotechnology1
Discover Chemistry.1
Egyptian Journal of Basic and Applied Sciences1
Intelligent Pharmacy1
Journal of Taibah University Medical Sciences1

How it can be read

75% free to read

Diamond 7 · 44%Free to read and to publish
Gold 5 · 31%In an open-access journal
Closed 4 · 25%Behind a paywall

Who funds it

3 of 16 papers name a funder

Ahmadu Bello University3

Development goals addressed

From each paper’s title and abstract

3Good health and well-being11
12Responsible consumption and production1

Most cited

In-silico activity prediction, structure-based drug design, molecular docking and pharmacokinetic studies of selected quinazoline derivatives for their antiproliferative activity against triple negative breast cancer (MDA-MB231) cell line
Bulletin of the National Research Centre/Bulletin of the National Research Center3
202259 citationsWorld top 10%Open access · Diamond
Molecular docking studies of some benzoxazole and benzothiazole derivatives as VEGFR-2 target inhibitors: In silico design, MD simulation, pharmacokinetics and DFT studies
Intelligent Pharmacy3
202349 citationsWorld top 10%Open access · Gold
Chemo-informatics activity prediction, ligand based drug design, Molecular docking and pharmacokinetics studies of some series of 4, 6-diaryl-2-pyrimidinamine derivatives as anti-cancer agents
Bulletin of the National Research Centre/Bulletin of the National Research Center3
202145 citationsWorld top 10%Open access · Diamond
Computational modeling, ligand-based drug design, drug-likeness and ADMET properties studies of series of chromen-2-ones analogues as anti-cancer agents
Bulletin of the National Research Centre/Bulletin of the National Research Center3
202240 citationsWorld top 10%Open access · Diamond
Molecular Docking , ADMET and Pharmacokinetic properties predictions of some di-aryl Pyridinamine derivatives as Estrogen Receptor (Er+) Kinase Inhibitors
Egyptian Journal of Basic and Applied Sciences3
202228 citationsWorld top 10%Open access · Diamond

2026

Scientific African

Journal

Open access

First author

Corresponding

0 citations

10.1016/j.sciaf.2026.e03402

Unveiling novel VEGFR-2 inhibitors: QSAR modeling, molecular docking, MD and MM-GBSA calculations, pharmacokinetics profiling and DFT studies

2025Scientific AfricanJournalOpen accessFirst authorCorresponding4 citations10.1016/j.sciaf.2025.e02692

Design of some phthalazine molecules as novel VEGFR-2 target inhibitors through 3D-QSAR modeling, molecular docking and dynamic simulation and pharmacokinetics profiling

2024Journal of Umm Al-Qura University for Applied SciencesJournalOpen accessCorresponding3 citations10.1007/s43994-024-00197-z

Design of novel BRC1A target inhibitors: Docking simulation, QSAR modeling, MD simulation and Pharmacokinetics profiling

2024Scientific AfricanJournalOpen accessFirst authorCorresponding2 citations10.1016/j.sciaf.2024.e02522

Molecular docking studies of some benzoxazole and benzothiazole derivatives as VEGFR-2 target inhibitors: In silico design, MD simulation, pharmacokinetics and DFT studies

2023Intelligent PharmacyJournalOpen accessFirst authorCorresponding49 citations10.1016/j.ipha.2023.11.010

Pharmacokinetic profiling of quinazoline-4(3H)-one analogs as EGFR inhibitors: 3D-QSAR modeling, molecular docking studies and the design of therapeutic agents

2023Journal of Taibah University Medical SciencesJournalOpen accessFirst authorCorresponding20 citations10.1016/j.jtumed.2023.02.015

Ligand-based drug design of quinazolin-4(3H)-ones as breast cancer inhibitors using QSAR modeling, molecular docking, and pharmacological profiling

2023Journal of the Egyptian National Cancer InstituteJournalOpen accessFirst authorCorresponding19 citations10.1186/s43046-023-00182-3

2D and 3D-QSAR Modeling of 1H‑Pyrazole Derivatives as EGFR Inhibitors: Molecular Docking, and Pharmacokinetic Profiling

2023Chemistry AfricaJournalFirst authorCorresponding16 citations10.1007/s42250-023-00592-9

Computational design of quinoxaline molecules as VEGFR-2 inhibitors: QSAR modelling, pharmacokinetics, molecular docking, and dynamics simulation studies

2023Biocatalysis and Agricultural BiotechnologyJournalFirst authorCorresponding16 citations10.1016/j.bcab.2023.102787

In-silico design of some pyrazolopyridine analogs as breast cancer inhibitors: QSAR modeling, molecular docking, MD simulation, and pharmacological features profiling

2023Journal of the Indian Chemical SocietyJournalFirst authorCorresponding8 citations10.1016/j.jics.2023.101053

In-silico activity prediction, structure-based drug design, molecular docking and pharmacokinetic studies of selected quinazoline derivatives for their antiproliferative activity against triple negative breast cancer (MDA-MB231) cell line

2022Bulletin of the National Research Centre/Bulletin of the National Research CenterJournalOpen accessFirst authorCorresponding59 citations10.1186/s42269-021-00690-z

Computational modeling, ligand-based drug design, drug-likeness and ADMET properties studies of series of chromen-2-ones analogues as anti-cancer agents

2022Bulletin of the National Research Centre/Bulletin of the National Research CenterJournalOpen accessFirst authorCorresponding40 citations10.1186/s42269-022-00869-y

Molecular Docking , ADMET and Pharmacokinetic properties predictions of some di-aryl Pyridinamine derivatives as Estrogen Receptor (Er+) Kinase Inhibitors

2022Egyptian Journal of Basic and Applied SciencesJournalOpen accessFirst authorCorresponding28 citations10.1080/2314808x.2022.2050115

Structure Based Design of Some Novel 3-Methylquinoxaline Derivatives Through Molecular Docking and Pharmacokinetics Studies as Novel VEGFR-2 Inhibitors

2022Chemistry AfricaJournalFirst authorCorresponding15 citations10.1007/s42250-022-00485-3

Chemo-informatics activity prediction, ligand based drug design, Molecular docking and pharmacokinetics studies of some series of 4, 6-diaryl-2-pyrimidinamine derivatives as anti-cancer agents

2021Bulletin of the National Research Centre/Bulletin of the National Research CenterJournalOpen accessFirst authorCorresponding45 citations10.1186/s42269-021-00631-w